Exercise Training for Heart Failure
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial focuses on improving exercise tolerance in individuals with heart failure with preserved ejection fraction (HFpEF), a condition where the heart struggles to pump blood effectively during physical activity. Researchers aim to determine if exercise training, a structured program of physical activity, can enhance muscle oxygen utilization, potentially improving daily activities and overall well-being. Participants will engage in a specific leg exercise routine three times a week for eight weeks. Those experiencing symptoms of HFpEF and who are not currently highly active might be suitable for this study. As an unphased trial, this study offers participants the chance to contribute to valuable research that could enhance the quality of life for those with HFpEF.
Do I have to stop taking my current medications for the trial?
You may need to stop taking certain medications like beta blockers or non-dihydropyridine calcium channel blockers for a short period before the trial. However, medications affecting the renin-angiotensin-aldosterone system and diuretics can be continued.
What prior data suggests that this exercise training is safe for heart failure patients?
Research has shown that exercise is safe for people with heart failure. In one study, over 300 exercise sessions resulted in only one minor issue (a participant fainted), suggesting that exercise is generally well-tolerated. Other studies support this, indicating that exercise is usually safe and can improve heart function and help patients walk farther.
Overall, exercise appears to be a safe way to enhance health in people with heart failure.12345Why are researchers excited about this trial?
Researchers are excited about exercise training for heart failure because it offers a natural and non-invasive approach to improve heart health. Unlike traditional treatments such as medications or surgical interventions, exercise training focuses on enhancing cardiovascular fitness and overall physical well-being. This method is particularly appealing as it empowers patients to actively participate in their own health management. Additionally, exercise can potentially reduce the need for more aggressive treatments by improving heart function and reducing symptoms, providing a holistic benefit that addresses both physical and mental health.
What evidence suggests that exercise training might be an effective treatment for heart failure?
Research has shown that exercise greatly benefits people with heart failure. Studies find it boosts fitness levels and improves quality of life. Exercise also helps the heart function better and reduces the risk of hospital readmission. For those with heart failure with preserved ejection fraction (HFpEF), exercise may enhance muscle oxygenation and facilitate activity. This trial will focus on exercise training to help individuals with HFpEF feel better and remain active.12456
Are You a Good Fit for This Trial?
This trial is for people over 65 with heart failure where the heart pumps normally but fills abnormally (HFpEF). They must show signs of heart failure, have a normal ejection fraction (>0.50), and evidence of diastolic dysfunction. Excluded are those with severe lung or advanced heart diseases, certain arrhythmias, heavy exercise habits, recent smokers, kidney issues, or on specific heart medications.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Initial assessments of vascular, metabolic, and neural function
Treatment
Participants undergo 8 weeks of single knee extensor exercise training
Post-Treatment Assessment
Re-assessment of vascular, metabolic, and neural function after exercise training
Follow-up
Participants are monitored for changes in exercise tolerance and physiological responses
What Are the Treatments Tested in This Trial?
Interventions
- Exercise training
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Texas Southwestern Medical Center
Lead Sponsor